Skip to main content
Clinical Trials/NCT01321840
NCT01321840CompletedNot Applicable

Investigation of Cortical Plasticity in a Complex Intervention for Endometriosis

University of Jena4 sites in 1 country60 target enrollmentStarted: March 1, 2010Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
60
Locations
4
Primary Endpoint
Brain function

Study Overview

Brief Summary

The aim of the study is to test, if patients suffering from Endometriosis show changes in their brain function, when being treated with SART (Systemic Autoregulation Therapy), a complex intervention consisting of interventions from Traditional Chinese Medicine (TCM) and Western Hypnotherapy. Functional and structural brain changes are assessed using Magnetic Resonance Imaging data which are analyzed by means of voxel-based morphometry (VBM), connectivity and perfusion analysis. A third outcome measure are changes of patients' heart rate variability, indicating the activity of their autonomic nervous system.

With a number of questionnaires, changes in dysmenorrhea, chronic pelvic pain, menstruation regularity, dyspareunia, defecation pain, and quality of life are assessed during the SART treatment.

During the treatment, we expect to see changes in cortical thickness, functional connectivity and perfusion of pain-related areas of the cortex, that correlate with the changes in heart rate variability.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Basic Science
Masking
Single (Outcomes Assessor)

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
Female
Accepts Healthy Volunteers
No

Inclusion Criteria

  • age > 18 years old
  • clinically or histologically ensured diagnosis of Endometriosis
  • preoperative and postoperative recurring ailments related to Endometriosis
  • no hormone therapy (GnRH analogues, contraceptives)
  • sufficient understanding of the German or English language
  • persisting pain during menstruation (also in between)
  • voluntary participation after information on the possible benefits and risks of the examination and intervention
  • written informed consent

Exclusion Criteria

  • alcohol addiction, drug addiction
  • pregnancy
  • diseases and other criteria, preventing an MRI examination:
  • pacemaker
  • neurostimulator or drug pump
  • metal parts in the body (implants, splinters, etc.)
  • claustrophobia

Outcomes

Primary Outcomes

Brain function

Time Frame: 12 weeks

Changes in cortical thickness, functional connectivity and perfusion of brain areas related to the processing of pain and emotions.

Secondary Outcomes

  • Reduction of pain(12 weeks)
  • Quality of life(12 wks)
  • Pain scores(12 wks)
  • Endometriosis-related symptoms(12 wks)
  • HRV (HF, LF, LF/HF)(12 wks)

Investigators

Sponsor
University of Jena
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Florian Beissner

Dr. phil. nat.

University of Jena

Study Sites (4)

Loading locations...

Similar Trials

Cortical Plasticity in a Complex... | Clinical Trial